Proteomic profiling of cholangiocarcinoma: Diagnostic potential of SELDI‐TOF MS in malignant bile duct stricture
Christopher J. Scarlett, Alex J. Saxby, AiQun Nielsen, Cameron Bell, Jaswinder S. Samra, Thomas Hugh, Robert C. Baxter, Ross C. Smith – 29 August 2006 – Proteomic techniques promise to improve the diagnosis of cholangiocarcinoma (CC) in both tissue and serum as histological diagnosis and existing serum markers exhibit poor sensitivities. We explored the use of surface‐enhanced laser desorption/ionization time‐of‐flight mass spectrometry (SELDI‐TOF MS) to identify potential protein biomarkers of CC. Twenty‐two resected CC samples were compared with adjacent noninvolved bile duct tissue.